{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:16:30Z","timestamp":1775063790016,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1186\/1471-2105-7-s2-s16","type":"journal-article","created":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T18:29:17Z","timestamp":1159295357000},"source":"Crossref","is-referenced-by-count":30,"title":["Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale)"],"prefix":"10.1186","volume":"7","author":[{"given":"Nan","family":"Mei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongming Andrew","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie L","family":"Moland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey L","family":"Dial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C","family":"Fuscoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,26]]},"reference":[{"issue":"1","key":"1310_CR1","first-page":"47","volume":"10","author":"KA Winship","year":"1991","unstructured":"Winship KA: Toxicity of comfrey. Adverse Drug React Toxicol Rev 1991, 10(1):47\u201359.","journal-title":"Adverse Drug React Toxicol Rev"},{"issue":"11","key":"1310_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0165-6147(02)02106-5","volume":"23","author":"D Rode","year":"2002","unstructured":"Rode D: Comfrey toxicity revisited. Trends Pharmacol Sci 2002, 23(11):497\u2013499. 10.1016\/S0165-6147(02)02106-5","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1310_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/DMR-120028426","volume":"36","author":"PP Fu","year":"2004","unstructured":"Fu PP, Xia Q, Lin G, Chou MW: Pyrrolizidinealkaloids \u2013 genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 2004, 36(1):1\u201355. 10.1081\/DMR-120028426","journal-title":"Drug Metab Rev"},{"issue":"1\u20132","key":"1310_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1383-5742(99)00010-1","volume":"443","author":"AS Prakash","year":"1999","unstructured":"Prakash AS, Pereira TN, Reilly PE, Seawright AA: Pyrrolizidine alkaloids in human diet. Mutat Res 1999, 443(1\u20132):53\u201367.","journal-title":"Mutat Res"},{"key":"1310_CR5","volume-title":"FDA","author":"USFDA, Center for Food Safety and Applied Nutrition","year":"2001","unstructured":"USFDA, Center for Food Safety and Applied Nutrition: FDA advises dietary supplement manufacturers to remove comfrey products from the market. FDA 2001. [ http:\/\/vm.cfsan.fda.gov\/~dms\/dspltr06.html ]"},{"issue":"6591","key":"1310_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/bmj.295.6591.183","volume":"295","author":"CF Weston","year":"1987","unstructured":"Weston CF, Cooper BT, Davies JD, Levine DF: Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br Med J (Clin Res Ed) 1987, 295(6591):183.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"1310_CR7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0016-5085(85)80027-5","volume":"88","author":"PM Ridker","year":"1985","unstructured":"Ridker PM, Ohkuma S, McDermott WV, Trey C, Huxtable RJ: Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 1985, 88(4):1050\u20131054.","journal-title":"Gastroenterology"},{"issue":"1","key":"1310_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD DeLeve","year":"2002","unstructured":"DeLeve LD, Shulman HM, McDonald GB: Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002, 22(1):27\u201342. 10.1055\/s-2002-23204","journal-title":"Semin Liver Dis"},{"issue":"3","key":"1310_CR9","first-page":"865","volume":"61","author":"I Hirono","year":"1978","unstructured":"Hirono I, Mori H, Haga M: Carcinogenic activity of Symphytum officinale. J Natl Cancer Inst 1978, 61(3):865\u2013869.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1310_CR10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/sj.bjc.6602420","volume":"92","author":"N Mei","year":"2005","unstructured":"Mei N, Guo L, Fu PP, Heflich RH, Chen T: Mutagenicity of comfrey (Symphytum Officinale) in rat liver. Br J Cancer 2005, 92(5):873\u2013875. 10.1038\/sj.bjc.6602420","journal-title":"Br J Cancer"},{"issue":"4","key":"1310_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/hep.1840380416","volume":"38","author":"LD DeLeve","year":"2003","unstructured":"DeLeve LD, Wang X, Kanel GC, Ito Y, Bethea NW, McCuskey MK, Tokes ZA, Tsai J, McCuskey RS: Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 2003, 38(4):900\u2013908. 10.1053\/jhep.2003.50383","journal-title":"Hepatology"},{"issue":"12","key":"1310_CR12","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1136\/gut.2005.065144","volume":"54","author":"V Paradis","year":"2005","unstructured":"Paradis V, Bieche I, Dargere D, Cazals-Hatem D, Laurendeau I, Saada V, Belghiti J, Bezeaud A, Vidaud M, Bedossa P, et al.: Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease. Gut 2005, 54(12):1776\u20131781. 10.1136\/gut.2005.065144","journal-title":"Gut"},{"issue":"2","key":"1310_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1021\/np0004653","volume":"64","author":"NC Kim","year":"2001","unstructured":"Kim NC, Oberlies NH, Brine DR, Handy RW, Wani MC, Wall ME: Isolation of symlandine from the roots of common comfrey (Symphytum officinale) using countercurrent chromatography. J Nat Prod 2001, 64(2):251\u2013253. 10.1021\/np0004653","journal-title":"J Nat Prod"},{"issue":"1","key":"1310_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/pca.715","volume":"15","author":"BT Schaneberg","year":"2004","unstructured":"Schaneberg BT, Molyneux RJ, Khan IA: Evaporative light scattering detection of pyrrolizidine alkaloids. Phytochem Anal 2004, 15(1):36\u201339. 10.1002\/pca.715","journal-title":"Phytochem Anal"},{"issue":"4A","key":"1310_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1017\/S1368980000000586","volume":"3","author":"F Stickel","year":"2000","unstructured":"Stickel F, Seitz HK: The efficacy and safety of comfrey. Public Health Nutr 2000, 3(4A):501\u2013508.","journal-title":"Public Health Nutr"},{"issue":"4","key":"1310_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/19960404NT3","volume":"4","author":"CE Couet","year":"1996","unstructured":"Couet CE, Crews C, Hanley AB: Analysis, separation, and bioassay of pyrrolizidine alkaloids from comfrey (Symphytum officinale). Nat Toxins 1996, 4(4):163\u2013167.","journal-title":"Nat Toxins"},{"issue":"17","key":"1310_CR17","first-page":"1095","volume":"315","author":"RJ Huxtable","year":"1986","unstructured":"Huxtable RJ, Luthy J, Zweifel U: Toxicity of comfrey-pepsin preparations. N Engl J Med 1986, 315(17):1095.","journal-title":"N Engl J Med"},{"issue":"1","key":"1310_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0002-9343(89)80492-9","volume":"87","author":"N Bach","year":"1989","unstructured":"Bach N, Thung SN, Schaffner F: Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med 1989, 87(1):97\u201399. 10.1016\/S0002-9343(89)80492-9","journal-title":"Am J Med"},{"issue":"8639","key":"1310_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(89)92154-5","volume":"1","author":"PM Ridker","year":"1989","unstructured":"Ridker PM, McDermott WV: Comfrey herb tea and hepatic veno-occlusive disease. Lancet 1989, 1(8639):657\u2013658. 10.1016\/S0140-6736(89)92154-5","journal-title":"Lancet"},{"issue":"2","key":"1310_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1440-1746.1990.tb01827.x","volume":"5","author":"ML Yeong","year":"1990","unstructured":"Yeong ML, Swinburn B, Kennedy M, Nicholson G: Hepatic veno-occlusive disease associated with comfrey ingestion. J Gastroenterol Hepatol 1990, 5(2):211\u2013214.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1310_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/00313029109061438","volume":"23","author":"ML Yeong","year":"1991","unstructured":"Yeong ML, Clark SP, Waring JM, Wilson RD, Wakefield SJ: The effects of comfrey derived pyrrolizidine alkaloids on rat liver. Pathology 1991, 23(1):35\u201338.","journal-title":"Pathology"},{"issue":"6","key":"1310_CR22","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hep.510290615","volume":"29","author":"LD DeLeve","year":"1999","unstructured":"DeLeve LD, McCuskey RS, Wang X, Hu L, McCuskey MK, Epstein RB, Kanel GC: Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999, 29(6):1779\u20131791. 10.1002\/hep.510290615","journal-title":"Hepatology"},{"issue":"5","key":"1310_CR23","first-page":"908","volume":"32","author":"DJ Svoboda","year":"1972","unstructured":"Svoboda DJ, Reddy JK: Malignant tumors in rats given lasiocarpine. Cancer Res 1972, 32(5):908\u2013913.","journal-title":"Cancer Res"},{"issue":"2","key":"1310_CR24","first-page":"469","volume":"63","author":"I Hirono","year":"1979","unstructured":"Hirono I, Haga M, Fujii M, Matsuura S, Matsubara N, Nakayama M, Furuya T, Hikichi M, Takanashi H, Uchida E, et al.: Induction of hepatic tumors in rats by senkirkine and symphytine. J Natl Cancer Inst 1979, 63(2):469\u2013472.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1310_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.lfs.2003.09.035","volume":"74","author":"S Zhou","year":"2004","unstructured":"Zhou S, Koh HL, Gao Y, Gong ZY, Lee EJ: Herbal bioactivation: the good, the bad and the ugly. Life Sci 2004, 74(8):935\u2013968. 10.1016\/j.lfs.2003.09.035","journal-title":"Life Sci"},{"issue":"6","key":"1310_CR26","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","volume":"89","author":"C Salat","year":"1997","unstructured":"Salat C, Holler E, Kolb HJ, Reinhardt B, Pihusch R, Wilmanns W, Hiller E: Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood 1997, 89(6):2184\u20132188.","journal-title":"Blood"},{"issue":"5","key":"1310_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4065\/78.5.589","volume":"78","author":"S Kumar","year":"2003","unstructured":"Kumar S, DeLeve LD, Kamath PS, Tefferi A: Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003, 78(5):589\u2013598.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"1310_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/152308602760598891","volume":"4","author":"M Bauer","year":"2002","unstructured":"Bauer M, Bauer I: Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress. Antioxid Redox Signal 2002, 4(5):749\u2013758. 10.1089\/152308602760598891","journal-title":"Antioxid Redox Signal"},{"issue":"65","key":"1310_CR29","first-page":"1393","volume":"52","author":"H Oe","year":"2005","unstructured":"Oe H, Kaido T, Mori A, Onodera H, Imamura M: Hepatocyte growth factor as well as vascular endothelial growth factor gene induction effectively promotes liver regeneration after hepatectomy in Solt-Farber rats. Hepatogastroenterology 2005, 52(65):1393\u20131397.","journal-title":"Hepatogastroenterology"},{"issue":"1\u20132","key":"1310_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0303-7207(02)00417-3","volume":"201","author":"EJ Gold","year":"2003","unstructured":"Gold EJ, Francis RJ, Zimmermann A, Mellor SL, Cranfield M, Risbridger GP, Groome NP, Wheatley AM, Fleming JS: Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis. Mol Cell Endocrinol 2003, 201(1\u20132):143\u2013153. 10.1016\/S0303-7207(02)00417-3","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"1310_CR31","first-page":"211","volume":"74","author":"ML Yeong","year":"1993","unstructured":"Yeong ML, Wakefield SJ, Ford HC: Hepatocyte membrane injury and bleb formation following low dose comfrey toxicity in rats. Int J Exp Pathol 1993, 74(2):211\u2013217.","journal-title":"Int J Exp Pathol"},{"issue":"2","key":"1310_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005, 115(2):209\u2013218. 10.1172\/JCI200524282","journal-title":"J Clin Invest"},{"issue":"1","key":"1310_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/gut.2003.024505","volume":"54","author":"S Sanz","year":"2005","unstructured":"Sanz S, Pucilowska JB, Liu S, Rodriguez-Ortigosa CM, Lund PK, Brenner DA, Fuller CR, Simmons JG, Pardo A, Martinez-Chantar ML, et al.: Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut 2005, 54(1):134\u2013141. 10.1136\/gut.2003.024505","journal-title":"Gut"},{"key":"1310_CR34","doi-asserted-by":"publisher","first-page":"d1899","DOI":"10.2741\/marra","volume":"7","author":"F Marra","year":"2002","unstructured":"Marra F: Chemokines in liver inflammation and fibrosis. Front Biosci 2002, 7: d1899\u20131914.","journal-title":"Front Biosci"},{"issue":"2","key":"1310_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2004.06.013","volume":"215","author":"N Mei","year":"2004","unstructured":"Mei N, Chou MW, Fu PP, Heflich RH, Chen T: Differential mutagenicity of riddelliine in liver endothelial and parenchymal cells of transgenic big blue rats. Cancer Lett 2004, 215(2):151\u2013158. 10.1016\/j.canlet.2004.06.013","journal-title":"Cancer Lett"},{"issue":"6","key":"1310_CR36","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1021\/tx049955b","volume":"17","author":"N Mei","year":"2004","unstructured":"Mei N, Heflich RH, Chou MW, Chen T: Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic big blue rats. Chem Res Toxicol 2004, 17(6):814\u2013818. 10.1021\/tx049955b","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"1310_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0041-008X(03)00165-0","volume":"191","author":"HL Hong","year":"2003","unstructured":"Hong HL, Ton TV, Devereux TR, Moomaw C, Clayton N, Chan P, Dunnick JK, Sills RC: Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. Toxicol Appl Pharmacol 2003, 191(3):227\u2013234. 10.1016\/S0041-008X(03)00165-0","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"1310_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/taap.2002.9485","volume":"184","author":"A Nyska","year":"2002","unstructured":"Nyska A, Moomaw CR, Foley JF, Maronpot RR, Malarkey DE, Cummings CA, Peddada S, Moyer CF, Allen DG, Travlos G, et al.: The hepatic endothelial carcinogen riddelliine induces endothelial apoptosis, mitosis, S phase, and p53 and hepatocytic vascular endothelial growth factor expression after short-term exposure. Toxicol Appl Pharmacol 2002, 184(3):153\u2013164. 10.1006\/taap.2002.9485","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"1310_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3181\/00379727-202-43511A","volume":"202","author":"H Hennings","year":"1993","unstructured":"Hennings H, Glick AB, Greenhalgh DA, Morgan DL, Strickland JE, Tennenbaum T, Yuspa SH: Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proc Soc Exp Biol Med 1993, 202(1):1\u20138.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"8","key":"1310_CR40","first-page":"3230","volume":"61","author":"LA Loeb","year":"2001","unstructured":"Loeb LA: A mutator phenotype in cancer. Cancer Res 2001, 61(8):3230\u20133239.","journal-title":"Cancer Res"},{"issue":"1","key":"1310_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/35094000","volume":"1","author":"EC Friedberg","year":"2001","unstructured":"Friedberg EC: How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001, 1(1):22\u201333. 10.1038\/35094000","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1310_CR42","first-page":"771","volume":"59","author":"DL Cheo","year":"1999","unstructured":"Cheo DL, Burns DK, Meira LB, Houle JF, Friedberg EC: Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-\/-mice. Cancer Res 1999, 59(4):771\u2013775.","journal-title":"Cancer Res"},{"issue":"8","key":"1310_CR43","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00535-003-1386-2","volume":"39","author":"Y Nakashima","year":"2004","unstructured":"Nakashima Y, Ono T, Yamanoi A, El-Assal ON, Kohno H, Nagasue N: Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Gastroenterol 2004, 39(8):763\u2013768. 10.1007\/s00535-003-1386-2","journal-title":"J Gastroenterol"},{"issue":"19","key":"1310_CR44","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3748\/wjg.v10.i19.2785","volume":"10","author":"IS Sheen","year":"2004","unstructured":"Sheen IS, Jeng KS, Wang PC, Shih SC, Chang WH, Wang HY, Chen CC, Shyung LR: Are gap junction gene connexins 26, 32 and 43 of prognostic values in hepatocellular carcinoma? A prospective study. World J Gastroenterol 2004, 10(19):2785\u20132790.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1310_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1572-0241.1999.00792.x","volume":"94","author":"TO Frommel","year":"1999","unstructured":"Frommel TO, Yong S, Zarling EJ: Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. Am J Gastroenterol 1999, 94(1):178\u2013182. 10.1111\/j.1572-0241.1999.00792.x","journal-title":"Am J Gastroenterol"},{"issue":"30","key":"1310_CR46","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.3748\/wjg.v11.i30.4740","volume":"11","author":"XX Duan","year":"2005","unstructured":"Duan XX, Ou JS, Li Y, Su JJ, Ou C, Yang C, Yue HF, Ban KC: Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis. World J Gastroenterol 2005, 11(30):4740\u20134744.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1310_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s005340170052","volume":"8","author":"T Kaido","year":"2001","unstructured":"Kaido T, Imamura M: Hepatocyte growth factor: clinical implications in hepatobiliary pancreatic surgery. J Hepatobiliary Pancreat Surg 2001, 8(1):65\u201375. 10.1007\/s005340170052","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"1","key":"1310_CR48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/carcin\/bgi202","volume":"27","author":"C Drucker","year":"2006","unstructured":"Drucker C, Parzefall W, Teufelhofer O, Grusch M, Ellinger A, Schulte-Hermann R, Grasl-Kraupp B: Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis. Carcinogenesis 2006, 27(1):152\u2013161. 10.1093\/carcin\/bgi202","journal-title":"Carcinogenesis"},{"key":"1310_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2156-5-27","volume":"5","author":"H Cangul","year":"2004","unstructured":"Cangul H: Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 2004, 5: 27. 10.1186\/1471-2156-5-27","journal-title":"BMC Genet"},{"issue":"5","key":"1310_CR50","first-page":"471","volume":"35","author":"J He","year":"2003","unstructured":"He J, Zhou R: [Correlation of NDRG1 gene with liver tissue differentiation and hepatocarcinogenesis]. Beijing Da Xue Xue Bao 2003, 35(5):471\u2013475.","journal-title":"Beijing Da Xue Xue Bao"},{"issue":"6","key":"1310_CR51","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1053\/jhep.2002.33683","volume":"35","author":"K Yasui","year":"2002","unstructured":"Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, Emi M, Inazawa J: TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 2002, 35(6):1476\u20131484. 10.1053\/jhep.2002.33683","journal-title":"Hepatology"},{"issue":"6750","key":"1310_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/45836","volume":"401","author":"CH Spruck","year":"1999","unstructured":"Spruck CH, Won KA, Reed SI: Deregulated cyclin E induces chromosome instability. Nature 1999, 401(6750):297\u2013300. 10.1038\/45836","journal-title":"Nature"},{"issue":"2","key":"1310_CR53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/13802","volume":"23","author":"MC Hollander","year":"1999","unstructured":"Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, et al.: Genomic instability in Gadd45a-deficient mice. Nat Genet 1999, 23(2):176\u2013184. 10.1038\/13802","journal-title":"Nat Genet"},{"issue":"11","key":"1310_CR54","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.humpath.2005.07.017","volume":"36","author":"L Gramantieri","year":"2005","unstructured":"Gramantieri L, Chieco P, Giovannini C, Lacchini M, Trere D, Grazi GL, Venturi A, Bolondi L: GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation. Hum Pathol 2005, 36(11):1154\u20131162. 10.1016\/j.humpath.2005.07.017","journal-title":"Hum Pathol"},{"issue":"6","key":"1310_CR55","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1053\/j.gastro.2005.09.010","volume":"129","author":"T Asselah","year":"2005","unstructured":"Asselah T, Bieche I, Laurendeau I, Paradis V, Vidaud D, Degott C, Martinot M, Bedossa P, Valla D, Vidaud M, et al.: Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 2005, 129(6):2064\u20132075. 10.1053\/j.gastro.2005.09.010","journal-title":"Gastroenterology"},{"issue":"2","key":"1310_CR56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0165-1161(94)90023-X","volume":"312","author":"NF Cariello","year":"1994","unstructured":"Cariello NF: Software for the analysis of mutations at the human hprt gene. Mutat Res 1994, 312(2):173\u2013185.","journal-title":"Mutat Res"},{"issue":"3","key":"1310_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0022-2836(87)90669-3","volume":"194","author":"WT Adams","year":"1987","unstructured":"Adams WT, Skopek TR: Statistical test for the comparison of samples from mutational spectra. J Mol Biol 1987, 194(3):391\u2013396. 10.1016\/0022-2836(87)90669-3","journal-title":"J Mol Biol"},{"issue":"Suppl 2","key":"1310_CR58","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1471-2105-6-S2-S6","volume":"6","author":"H Fang","year":"2005","unstructured":"Fang H, Tong W, Perkins R, Shi L, Hong H, Cao X, Xie Q, Yim SH, Ward JM, Pitot HC, et al.: Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling. BMC Bioinformatics 2005, 6(Suppl 2):S6. [http:\/\/] 10.1186\/1471-2105\/6\/S2\/S6","journal-title":"BMC Bioinformatics"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-7-S2-S16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2105-7-S2-S16\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-7-S2-S16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T10:02:28Z","timestamp":1587204148000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-7-S2-S16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":58,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-7-s2-s16","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]},"article-number":"S16"}}